About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Heart Disease News » FDA Panel Votes in Favor of Abbott’s MitraClip Device to Treat Heart Valve Defect

FDA Panel Votes in Favor of Abbott’s MitraClip Device to Treat Heart Valve Defect

by Raja Nandhini on Mar 22 2013 4:33 AM

FDA Panel Votes in Favor of Abbott’s MitraClip Device to Treat Heart Valve Defect

The FDA’s Circulatory System Devices advisory panel has voted in favor of Abbott Laboratories’ MitraClip device, which is used to treat a heart valve problem, mitral regurgitation. The device is only recommended for patients who are at an increased risk for an open heart surgery.

There were mixed responses from the panelists regarding the efficacy of the device in improving the condition of the patients due to the lack of sufficient randomized clinical trial data. The members struggled to identify the patient groups who really benefitted from the device.

Clinical Trials and Its different Phases

Clinical Trials and Its different Phases
Clinical trials serve as a vital component for improving the treatment of medical conditions as they lead to higher standards of patient care.

However, after a long discussion, the panel voted 5-3 in favor of the device. They were unanimous regarding the device safety.

MitraClip is currently being sold in 30 countries. Abbott awaits the FDA’s final decision.

Source-Medindia

Half of Eligible Patients Not Getting Mitral Valve Surgery: Study

Half of Eligible Patients Not Getting Mitral Valve Surgery: Study
ANN ARBOR, Mich. – Overblown fears about surgical risk and lack of awareness about the risk of not operating are among the reasons only half of eligible patients were referred for

Evaluating the Effectiveness of Percutaneous Valve Therapy

Evaluating the Effectiveness of Percutaneous Valve Therapy
The rapidly advancing field within interventional cardiology: percutaneous procedures to repair and replace defective heart valves will be assessed extensively by researchers.

Recommended Readings

Mitral Valve Prolapse

Mitral Valve Prolapse

Mitral Valve Prolapse is a relatively common condition and causes leakage of blood through the valve. MVP is not life-threatening in most instances.

Statins

Statins are new wonder drugs that are proving to be efficacious, not merely in relieving symptoms but also offering several health benefits.

Prosthetic Heart Valves

Prosthetic Heart Valves

A prosthetic heart valve is an artificial device surgically implanted into the heart to replace a heart valve that has become damaged.

Pericarditis

Pericarditis occurs when the pericardium gets inflamed. Pericarditis is characterized by severe chest pain.

Aortic Valve Stenosis

Aortic Valve Stenosis

Aortic valve Stenosis is an abnormal narrowing of the c valve. Symptoms include angina, and that of heart failure. Aortic valve replacement is effective therapy.

Bicuspid Aortic Valve

Bicuspid Aortic Valve

Bicuspid aortic valve is a congenital condition where the aortic valve has only two leaflets instead of the normal three-leaflet shape.

Latest Heart Disease News

Atrial Fibrillation Common Among Young Individuals

Atrial Fibrillation Common Among Young Individuals

Younger patients with Afib faced higher hospitalization rates for heart failure, stroke, or heart attack, along with elevated comorbidity and mortality rates.

Rising Lifetime Risk of Atrial Fibrillation and Its Complications

Rising Lifetime Risk of Atrial Fibrillation and Its Complications

Study reveals increasing lifetime risk of atrial fibrillation, emphasizing urgent need for preventive strategies against stroke and heart failure in affected individuals.

Effective Nasal Spray Therapy for Recurrent Abnormal Heart Rhythms

Effective Nasal Spray Therapy for Recurrent Abnormal Heart Rhythms

Etripamil nasal spray, self-administered at home, was found to relieve recurrent rapid abnormal heart rhythms.

Take Charge of Your Health

Take Charge of Your Health

A report from India indicates a surge in cancer rates among young Indians. Approximately 75% are overweight, with obesity rates doubling from 9% in 2016 to 20% in 2023.

Anti-Inflammatory Proteins Post-Heart Attack Reduce Further Damage Risk

Anti-Inflammatory Proteins Post-Heart Attack Reduce Further Damage Risk

The potential of using HpTGM as an anti-inflammatory therapy for heart attack patients is an exciting prospect that merits further translational studies.

Advertisement